Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

New perspectives for the treatment of disorders of sleep and arousal.

Sanger DJ, Soubrane C, Scatton B.

Ann Pharm Fr. 2007 Jul;65(4):268-74. Review.

PMID:
17652996
2.

The search for novel antipsychotics: pharmacological and molecular targets.

Sanger DJ.

Expert Opin Ther Targets. 2004 Dec;8(6):631-41. Review.

PMID:
15584867
3.

The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents.

Sanger DJ.

CNS Drugs. 2004;18 Suppl 1:9-15; discussion 41, 43-5. Review.

PMID:
15291009
4.

The preclinical pharmacologic profile of tiapride.

Scatton B, Cohen C, Perrault G, Oblin A, Claustre Y, Schoemaker H, Sanger DJ, Rouquier L, Porsolt R.

Eur Psychiatry. 2001 Jan;16 Suppl 1:29s-34s.

PMID:
11520476
5.

Pharmacological and molecular targets in the search for novel antipsychotics.

Scatton B, Sanger DJ.

Behav Pharmacol. 2000 Jun;11(3-4):243-56. Review.

PMID:
11103879
6.

The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety.

Griebel G, Rodgers RJ, Perrault G, Sanger DJ.

Neuropharmacology. 2000 Jul 24;39(10):1848-57.

PMID:
10884565
7.

Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies.

Blondel A, Sanger DJ, Moser PC.

Psychopharmacology (Berl). 2000 Apr;149(3):293-305.

PMID:
10823411
8.

The effect of repeated nicotine administration on the performance of drug-naive rats in a five-choice serial reaction time task.

Blondel A, Simon H, Sanger DJ, Moser P.

Behav Pharmacol. 1999 Nov;10(6-7):665-73.

PMID:
10780508
9.
10.

Comparison of the pharmacological properties of classical and novel BZ-omega receptor ligands.

Griebel G, Perrault G, Tan S, Schoemaker H, Sanger DJ.

Behav Pharmacol. 1999 Sep;10(5):483-95.

PMID:
10780255
11.

Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice.

Boulay D, Depoortere R, Oblin A, Sanger DJ, Schoemaker H, Perrault G.

Eur J Pharmacol. 2000 Mar 10;391(1-2):63-73.

PMID:
10720636
12.

Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice.

Griebel G, Belzung C, Perrault G, Sanger DJ.

Psychopharmacology (Berl). 2000 Feb;148(2):164-70.

PMID:
10663431
13.

Decreased locomotor activity after microinjection of dopamine D2/D3 receptor agonists and antagonists into lobule 9/10 of the cerebellum: a D3 receptor mediated effect?

Boulay D, Depoortere R, Perrault G, Sanger DJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2000 Jan;24(1):39-49.

PMID:
10659982
14.

The D3 antagonist PNU-99194A potentiates the discriminative cue produced by the D3 agonist 7-OH-DPAT.

Depoortere R, Perrault G, Sanger DJ.

Pharmacol Biochem Behav. 2000 Jan 1;65(1):31-4.

PMID:
10638632
15.

Reduction of oral ethanol self-administration in rats by monoamine oxidase inhibitors.

Cohen C, Curet O, Perrault G, Sanger DJ.

Pharmacol Biochem Behav. 1999 Nov;64(3):535-9.

PMID:
10548268
16.

New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes.

Griebel G, Perrault G, Letang V, Granger P, Avenet P, Schoemaker H, Sanger DJ.

Psychopharmacology (Berl). 1999 Sep;146(2):205-13.

PMID:
10525757
17.

Discriminative stimulus effects of drugs acting at GABA(A) receptors: differential profiles and receptor selectivity.

Sanger DJ, Griebel G, Perrault G, Claustre Y, Schoemaker H.

Pharmacol Biochem Behav. 1999 Oct;64(2):269-73. Review.

PMID:
10515302
18.

Behavioral effects of acute and chronic fluoxetine in Wistar-Kyoto rats.

Griebel G, Cohen C, Perrault G, Sanger DJ.

Physiol Behav. 1999 Sep;67(3):315-20.

PMID:
10497947
19.

Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists.

Boulay D, Depoortere R, Perrault G, Borrelli E, Sanger DJ.

Neuropharmacology. 1999 Sep;38(9):1389-96.

PMID:
10471093
20.

Pharmacological studies on synthetic flavonoids: comparison with diazepam.

Griebel G, Perrault G, Tan S, Schoemaker H, Sanger DJ.

Neuropharmacology. 1999 Jul;38(7):965-77.

PMID:
10428415
21.

Orphanin FQ, a novel neuropeptide with anti-stress-like activity.

Griebel G, Perrault G, Sanger DJ.

Brain Res. 1999 Jul 31;836(1-2):221-4.

PMID:
10415424
22.
23.

Behavioural profiles in the mouse defence test battery suggest anxiolytic potential of 5-HT(1A) receptor antagonists.

Griebel G, Rodgers RJ, Perrault G, Sanger DJ.

Psychopharmacology (Berl). 1999 May;144(2):121-30.

PMID:
10394992
24.
25.

Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice.

Boulay D, Depoortere R, Rostene W, Perrault G, Sanger DJ.

Neuropharmacology. 1999 Apr;38(4):555-65.

PMID:
10221759
26.
27.
28.
29.

Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents.

Griebel G, Perrault G, Sanger DJ.

J Psychopharmacol. 1998;12(4):356-65.

PMID:
10065909
30.
31.

Assessment of the antidepressant-like effects of L-type voltage-dependent channel modulators.

Cohen C, Perrault G, Sanger DJ.

Behav Pharmacol. 1997 Nov;8(6-7):629-38.

PMID:
9832975
33.

The Pharmacology and Mechanism of Action of Zolpidem.

Sanger DJ, Depoortere H.

CNS Drug Rev. 1998 Dec;4(4):323-340. doi: 10.1111/j.1527-3458.1998.tb00074.x. No abstract available.

36.
38.
39.
40.

Characterization of the discriminative stimulus produced by the dopamine antagonist tiapride.

Cohen C, Sanger DJ, Perrault G.

J Pharmacol Exp Ther. 1997 Nov;283(2):566-73.

PMID:
9353371
41.

Quantitative motor assessment in FALS mice: a longitudinal study.

Barnéoud P, Lolivier J, Sanger DJ, Scatton B, Moser P.

Neuroreport. 1997 Sep 8;8(13):2861-5.

PMID:
9376520
42.
43.

The effects of new hypnotic drugs in rats trained to discriminate ethanol.

Sanger DJ.

Behav Pharmacol. 1997 Aug;8(4):287-92.

PMID:
9832988
44.
45.

Evidence for the involvement of dopamine receptors in ethanol-induced hyperactivity in mice.

Cohen C, Perrault G, Sanger DJ.

Neuropharmacology. 1997 Aug;36(8):1099-108.

PMID:
9294975
46.

Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test.

Griebel G, Rodgers RJ, Perrault G, Sanger DJ.

Pharmacol Biochem Behav. 1997 Aug;57(4):817-27.

PMID:
9259011
47.
48.

Amisulpride: from animal pharmacology to therapeutic action.

Scatton B, Claustre Y, Cudennec A, Oblin A, Perrault G, Sanger DJ, Schoemaker H.

Int Clin Psychopharmacol. 1997 May;12 Suppl 2:S29-36. Review.

PMID:
9218165
50.

Discriminative stimulus effects of apomorphine and 7-OH-DPAT: a potential role for dopamine D3 receptors.

Sanger DJ, Depoortere R, Perrault G.

Psychopharmacology (Berl). 1997 Apr;130(4):387-95.

PMID:
9160856

Supplemental Content

Loading ...
Support Center